Mentopin

Acetylcysteine.

Each effervescent tablet contains 600 mg Acetylcysteine.
Excipients/Inactive Ingredients: Citric acid, Sodium hydrogen carbonate, Sodium carbonate, Mannitol, Lactose, Sodium cyclamate, Saccharin sodium, Sodium citrate, Flavour Lemon "AU", code 132.

It is used to make mucus thinner and easier to cough up in bronchitis associated with the common cold. MENTOPIN Acetylcysteine 600 is a medicine that is used to make sticky mucus in the airways thinner.
Therapeutic Indications: To loosen mucus and make it easier to cough up in respiratory tract conditions associated with sticky mucus. The patient must talk to a doctor if he or she do not feel better or worse after 4-5 days.

Check with the doctor or pharmacist if not sure.
The recommended dose is: Adolescents over 14 years of age and adults: 1 effervescent tablet once daily.
Method of administration and total duration of use: If the patient's condition gets worse or does not get better after 4-5 days, the patient should see a doctor.
Take MENTOPIN Acetylcysteine 600 after meals.
Dissolve the MENTOPIN Acetylcysteine 600 in a glass of drinking water and drink all of the solution in the glass.
Note: The patient may notice a smell of sulphur.

An overdose may cause symptoms of irritation in the gastrointestinal tract (e.g. abdominal pain, nausea, vomiting, diarrhoea).
Serious side effects or symptoms of poisoning have not yet been observed even after massive overdoses of Acetylcysteine tablets. The patient should still notify the doctor if he/she suspects an overdose with MENTOPIN Acetylcysteine 600.
If the patient forgets to take MENTOPIN Acetylcysteine 600: Do not take a double dose to make up for a forgotten dose.
If the patient stops taking MENTOPIN Acetylcysteine 600: Do not stop taking MENTOPIN Acetylcysteine 600 without consulting the doctor first. If the patient does, the condition might get worse.
If the patient has any further questions on the use of this medicine, ask the doctor or pharmacist.

If the patient is allergic to Acetylcysteine or any of the other ingredients of this medicine (see Description).

There have been very rare reports of the occurrence of severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis in temporal association with the use of Acetylcysteine. Therefore, if the patient develops any new skin and mucosal changes, the patient should seek medical advice and stop using Acetylcysteine straight away.
Caution should be exercised if the patient has bronchial asthma or has ever had or have a stomach or intestinal ulcer.
Caution should be exercised in patients with histamine intolerance. Prolonged treatment should be avoided in these patients because MENTOPIN Acetylcysteine 600 interferes with histamine metabolism and may lead to intolerance symptoms (e.g. headache, rhinitis, itching).
MENTOPIN Acetylcysteine 600 contains sodium and lactose: Each effervescent tablet contains 6 mmol (138.8 mg) sodium. To be taken into consideration by patients on a controlled sodium diet. This medicine contains lactose. Therefore, if the patient have been told by the doctor that he/she has an intolerance to some sugars, contact the doctor before taking MENTOPIN Acetylcysteine 600.
Use in children: MENTOPIN Acetylcysteine 600 must not be used in children under 14 years of age because of its high substance content.
Driving and using machines: No special precautions need to be taken into consideration.

If the patient is pregnant or breast-feeding, may be pregnant or are planning to have a baby, ask the doctor or pharmacist for advice before taking this medicine.
Pregnancy: As no adequate experience with the use of Acetylcysteine in pregnant women is available, the patient should not use MENTOPIN Acetylcysteine 600 during pregnancy unless the treating doctor considers this absolutely necessary.
Breast-feeding: No information is available on the excretion of Acetylcysteine in breast milk. Therefore, the patient should not use MENTOPIN Acetylcysteine 600 whilst breast-feeding unless the treating doctor considers this absolutely necessary.

Like all medicines, this medicine can cause side effects, although not everybody gets them. The reported frequencies of side effects are based on the following categories: Very common: more than 1 out of 10 patients taking this medicine.
Common: less than 1 out of 10, but more than 1 out of 100 patients taking this medicine.
Uncommon: less than 1 out of 100, but more than 1 out of 1000 patients taking this medicine.
Rare: less than 1 out of 1000, but more than 1 out of 10,000 patients taking this medicine.
Very rare: less than 1 out of 10,000 patients taking this medicine, including isolated cases.
Not known: cannot be estimated from the available data.
Generalised disorders (uncommon): Headache, fever/allergic reactions, itching, whealing, skin rash, shortness of breath, acceleration of the heart beat and blood pressure reduction, as well as swelling of the skin and mucous membranes, especially in the face.
Respiratory tract (rare): Shortness of breath, bronchospasms predominantly in patients with a hyperreactive bronchial system in bronchial asthma.
Digestive tract (uncommon): Inflammation of the oral mucosa, abdominal pain, nausea, vomiting and diarrhoea.
There have been very rare reports of bleeding associated with the administration of Acetylcysteine, and some of these bleeding episodes occurred as part of hypersensitivity reactions.
Countermeasures: MENTOPIN Acetylcysteine 600 must not be taken again after the first signs of a hypersensitivity reaction (see Contraindications). If this happens, contact a doctor.
If the patient gets any side effects, talk to the doctor or pharmacist. This includes any possible side effects not mentioned in the texts.

Tell the doctor or pharmacist if the patient is taking, have recently taken or might take any other medicines.
Acetylcysteine/antitussives: When MENTOPIN Acetylcysteine 600 is used in combination with cough suppressants (antitussives), the reduced cough reflex may lead to dangerous stasis of secretions. Particular caution should therefore be exercised when using this combination. Therefore, be sure to consult the doctor prior to combined use.
Acetylcysteine/antibiotics: There is evidence from experimental studies to suggest that Acetylcysteine decreases the effect of antibiotics (tetracycline, aminoglycosides, penicillins). For safety considerations, antibiotics should therefore be taken separately and at least two hours apart from Acetylcysteine.

Store below 30°C in a dry place away from moisture.
Do not throw away any medicines via wastewater or household waste. Ask the pharmacist hot to throw medicines that is no longer use. These measures will help protect the environment.

Cough & Cold Preparations

R05CB01 - acetylcysteine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.

P